Tatsuya Yoshida
0000-0003-4896-5824
1 paper found
Refreshing results…
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
Missing publications? Search for publications with a matching author name.